Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer

NCT03474861 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Cancer

Interventions

BIOLOGICAL: anticancer medication A01; immune cells IC01

Sponsor

Hangzhou Converd Co., Ltd.

Collaborators

[object Object]